Processing

Please wait...

Settings

Settings

Goto Application

1. WO2002000883 - RESCUE OF CANINE DISTEMPER VIRUS FROM CDNA

Publication Number WO/2002/000883
Publication Date 03.01.2002
International Application No. PCT/US2001/020157
International Filing Date 22.06.2001
Chapter 2 Demand Filed 21.01.2002
IPC
C07K 14/12 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
115Paramyxoviridae, e.g. parainfluenza virus
12Mumps virus; Measles virus
C07K 14/13 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
115Paramyxoviridae, e.g. parainfluenza virus
13Canine distemper virus
C12N 7/00 2006.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
7Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
CPC
A61K 2039/5256
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
51comprising whole cells, viruses or DNA/RNA
525Virus
5256expressing foreign proteins
A61P 31/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
A61P 31/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
C07K 14/005
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
C12N 15/11
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
11DNA or RNA fragments; Modified forms thereof
C12N 2760/18422
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2760ssRNA Viruses negative-sense
00011ssRNA Viruses negative-sense
18011Paramyxoviridae
18411Morbillivirus, e.g. Measles virus, canine distemper
18422New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applicants
  • AMERICAN CYANAMID COMPANY [US]/[US] (AllExceptUS)
  • PARKS, Christopher, L. [US]/[US] (UsOnly)
  • SIDHU, Mohinderjit, S. [US]/[US] (UsOnly)
  • WALPITA, Pramila [US]/[US] (UsOnly)
  • KOVACS, Gerald, R. [US]/[US] (UsOnly)
  • UDEM, Stephen, A. [US]/[US] (UsOnly)
Inventors
  • PARKS, Christopher, L.
  • SIDHU, Mohinderjit, S.
  • WALPITA, Pramila
  • KOVACS, Gerald, R.
  • UDEM, Stephen, A.
Agents
  • WEBSTER, Darryl, L.
  • WILEMAN, David, Francis
Priority Data
60/213,69823.06.2000US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) RESCUE OF CANINE DISTEMPER VIRUS FROM CDNA
(FR) SAUVETAGE DU VIRUS DE LA MALADIE DE CARRE PAR L'ADN
Abstract
(EN) This invention relates to a method for recombinantly producing via rescue canine distemper virus, a nonsegmented, negative-sense, single-stranded RNA virus, and immunogenic compositions formed therefrom. Additional embodiments relate to methods of producing the canine distemper virus as an attenuated and/or infectious viruses. The recombinant viruses can be prepared from cDNA clones, and, accordingly, viruses having defined changes, including nucleotide/polynucleotide deletions, insertions, substitutions and rearrangements, in the genome can be obtained.
(FR) Cette invention porte sur un procédé de production par recombinaison, via la technique du sauvetage du virus de la maladie de Carré, d'un virus d'ARN monobrin, sens négatif, non segmenté, et sur des compositions immunogènes obtenues. Selon d'autres réalisation, l'invention porte sur des procédés de production du virus de la maladie de Carré sous forme d'un virus atténué et/ou infectieux. Les virus recombinés peuvent être préparés à partir de clones d'ADNc et, en conséquence, il est possible d'obtenir des virus présentant des modifications définies comprenant des délétions nucléotidiques/polynucléotidiques, des insertions, des substitutions et des transpositions, dans le génome.
Related patent documents
IL152930This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau